Evidence map›Paper›PMID 38346934›Full record

ArticleAge and ageing2024

Disentangling the reasons why older adults do not readily participate in cancer trials: a socio-epidemiological mixed methods approach.

Meoïn Hagège, Michaël Bringuier, Claudia Martinez-Tapia, Christos Chouaïd, Carole Helissey, Etienne Brain, Godelieve Rochette Lempdes, Coraline Dubot, Diana Bello-Roufai, Romain Geiss and 7 more

Abstract read
In one paragraph

Article in Age and ageing, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Increasing Diversity in Head and Neck Cancer Clinical Trials.Current treatment options in oncology · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Meoïn HagègeDepartment of Health, French institute for health research, Institut Mondor de Recherche Biomédicale, InsermU955, Eq. CEpiA & University Paris Est Créteil, 8 rue du general Sarrail, F-94010 Créteil, France.ORCID 0000-0002-5863-8870
Michaël BringuierInstitut Curie, 35 Rue Dailly, F-92210 Saint-Cloud, France.ORCID 0000-0002-7643-2956
Claudia Martinez-TapiaDepartment of Health, French institute for health research, Institut Mondor de Recherche Biomédicale, InsermU955, Eq. CEpiA & University Paris Est Créteil, 8 rue du general Sarrail, F-94010 Créteil, France.
Christos ChouaïdDepartment of Health, French institute for health research, Institut Mondor de Recherche Biomédicale, InsermU955, Eq. CEpiA & University Paris Est Créteil, 8 rue du general Sarrail, F-94010 Créteil, France.
Carole HelisseyDepartement of Oncology, Hôpital d'Instruction des Armées Bégin, 69 Av. de Paris, F-94160 Saint-Mandé, France.
Etienne BrainInstitut Curie, 35 Rue Dailly, F-92210 Saint-Cloud, France.
Godelieve Rochette LempdesInstitut Curie, 35 Rue Dailly, F-92210 Saint-Cloud, France.
Coraline DubotInstitut Curie, 35 Rue Dailly, F-92210 Saint-Cloud, France.
Diana Bello-RoufaiInstitut Curie, 35 Rue Dailly, F-92210 Saint-Cloud, France.
Romain GeissInstitut Curie, 35 Rue Dailly, F-92210 Saint-Cloud, France.
Emmanuelle KempfDepartment of Oncology, Hôpital Henri Mondor, 54 avenue du maréchal lattre de tassigny, F-94010 Créteil, France.
Audrey GourdenDepartement of Oncology, Hôpital d'Instruction des Armées Bégin, 69 Av. de Paris, F-94160 Saint-Mandé, France.
Hanane ElgharbiDepartment of Pneumology, Centre Hospitalier Intercommunal  Créteil, 40 Av. de Verdun, F-94000 Créteil, France.
Sonia GarrigouDepartment of Oncology, Hôpital Henri Mondor, 54 avenue du maréchal lattre de tassigny, F-94010 Créteil, France.
Laetitia GregoireDepartment of Oncology, Hôpital Henri Mondor, 54 avenue du maréchal lattre de tassigny, F-94010 Créteil, France.
Benjamin DerbezDepartment of Sociology, Université Paris 8, Cresspa CSU, 2 Rue de la Liberté, F-93200 Saint-Denis, France.
Florence Canouï-PoitrineDepartment of Health, French institute for health research, Institut Mondor de Recherche Biomédicale, InsermU955, Eq. CEpiA & University Paris Est Créteil, 8 rue du general Sarrail, F-94010 Créteil, France.

Funding

INCa SHS-ESP 2015Mondor Hospital, Créteil, France 00011558
6 · The paper itself

Abstract

backgroundFew studies of the under-representation of older adults in cancer clinical trials (CTs) have encompassed the entire pathway from a trial being available in a cancer centre to the patient's invitation to participate and then agreement or refusal to participate.

objectivesThe study's primary objective was to evaluate CT non-invitation and refusal rates. The secondary objectives were to identify factors associated with non-invitation and refusal and to assess experiences of CT participation from the patients' and professionals' perspectives.

methodsHere, we used mixed methods and a socio-epidemiological approach to analyse reasons for the non-participation of eligible older patients with a solid cancer in cancer CTs in France.

resultsWe found that non-invitation and low CT participation are mainly related to the patients' sociodemographic characteristics and living conditions (such as social isolation, being single, divorced or widowed, not having children and the absence of close family members) and the healthcare professionals' perceptions of insufficient informal support or a high homecare requirement.

conclusionOur results suggest that efforts to increase fair inclusion and the participation of older adults in CTs should target the physician-patient relationship, the medical profession and hospital funding, rather than the patient alone.

Indexed as

NeoplasmsAgedFranceHumansPhysician-Patient Relationscancer trialinclusionnon-invitationolder peopleparticipationrefusal to participate

Identifiers

PMID38346934
PMCPMC10861365

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.